Nasal Sprays / Sprays Available for Third Party / CMO

Sodium Chloride & Benzalkonium

Sodium Chloride & Benzalkonium Chloride Nasal Solution IP · Respiratory, Cough & Cold

WHO-GMP DCGI Approved Baddi, HP
240+ DCGI Formulations
2050+ Global Partners
21+ Years Legacy
NASAL SPRAY PRESENTATION (AVAILABLE VARIANTS):
Formulated in Isotonic & Hypertonic variants:
Sodium Chloride IP (Isotonic Variant)
0.65 % w/v
Sodium Chloride IP (Hypertonic Variant)
2.6 % w/v
Benzalkonium Chloride IP (Preservative)
0.01 % w/v
Aqueous Sterile Base
q.s.
Product Data Sheet
Segments & Ranges Nasal Sprays / Sprays
Dosage Form Nasal Spray / Drops
Pharma Class Respiratory / Cough & Cold
Pack Sizes 10 ml / 15 ml / 20 ml
Storage Condition Store below 30°C in a dry place. Protect from direct sunlight. Do not freeze.
Stability / Shelf Life 24 Months
Manufacturing Location Baddi, Himachal Pradesh
Corporate Office Chandigarh
Compliance DCGI Approved / Schedule M
Facility Grade ISO Class 7 Cleanroom Sterile Filling
Available Formulations Isotonic (0.65%) & Hypertonic (2.6%)
Schedule M Compliant
Private Label Ready
Pan-India Dispatch
WHO-GMP ISO 9001:2015 GLP Certified DCGI Approved Schedule M

Product Profile

Sodium Chloride and Benzalkonium Chloride Nasal Spray is a highly versatile, drug-free formulation essential for the management of nasal congestion, allergic rhinitis, and post-operative sinus care. As a premier WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech utilizes ISO Class 7 cleanroom sterile filling to ensure our nasal solutions deliver uncompromised purity, precise micro-mist dispersion, and rapid mucosal relief.

Manufacturing Advantage

Why Saar Biotech for Sodium Chloride & Benzalkonium?

Since {{ site.Params.founded }}, Saar Biotech has been a distinguished WHO-GMP certified leader in pharmaceutical manufacturing. We utilize advanced micronization and pH-stabilization protocols to deliver unmatched bioavailability for this Sodium Chloride & Benzalkonium formulation.

DCGI Approved

Comprehensive documentation and CDSCO support for rapid market entry in India.

Fast Turnaround

30-45 days lead time for new batches with state-of-the-art logistics.

Pan-India Supply & Contract Manufacturing

Batch Lead Time 30-45 Days (Domestic)
B2B Services Contract & Third-Party
Compliance DCGI & Schedule M Standards
Medical Intelligence

Clinical Q&A for Sodium Chloride & Benzalkonium

Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.

What are the primary clinical indications for Sodium Chloride Nasal Sprays?

Sodium Chloride nasal sprays are clinically indicated for the relief of nasal congestion, stuffiness, and post-nasal drip associated with viral upper respiratory infections, allergic rhinitis, and sinusitis. They are also highly recommended for post-operative care, specifically following Functional Endoscopic Sinus Surgery (FESS), to keep the nasal passages moist and remove crusted mucus.

What is the clinical difference between the 0.65% and 2.6% formulations?

The 0.65% formulation is an Isotonic solution, designed primarily to moisturize dry nasal passages and gently flush out allergens like dust and pollen. The 2.6% formulation is a Hypertonic solution. Because it has a higher salt concentration than the body’s tissues, it creates an osmotic gradient that actively draws excess fluid out of swollen nasal mucosa, providing highly effective, drug-free decongestion.

What is the role of Benzalkonium Chloride in this nasal formulation?

Benzalkonium Chloride (BKC) is a quaternary ammonium compound that acts as a highly effective antimicrobial preservative and cationic surfactant. In the nasal spray, it ensures the sterility of the multi-dose bottle after opening by disrupting the lipid bilayers of introduced bacteria, while its surfactant properties help the saline solution spread evenly across the nasal mucosa.

Is this nasal spray safe for pediatric use and long-term application?

Yes, unlike medicated decongestant sprays (such as oxymetazoline or xylometazoline) which can cause rebound congestion (rhinitis medicamentosa) if used for more than a few days, Sodium Chloride sprays are completely drug-free. They can be used safely over the long term by adults, pregnant women, and pediatric patients without the risk of dependency or mucosal damage.

Are there any contraindications for saline nasal sprays?

While topically applied saline is exceptionally safe, the systemic absorption of large volumes of sodium is a theoretical risk. Therefore, it is technically contraindicated in patients with severe congestive heart failure, extreme renal impairment, conditions of sodium retention, severe edema, or liver cirrhosis, though standard nasal application rarely delivers systemic sodium loads of clinical significance.
Manufacturing Support

B2B Manufacturing Guide for Sodium Chloride & Benzalkonium

Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.

What packaging and actuator options are available for these nasal sprays?
The commercial success of a nasal spray depends heavily on the pump actuator. We utilize pharmaceutical-grade HDPE or PET squeeze bottles (for drops/spray combo) as well as premium metered-dose pump actuators. Our pumps deliver a precisely calibrated micro-mist, ensuring uniform droplet size for optimal mucosal coverage without leakage or dripping.
What is the MOQ for third-party manufacturing of the 10ml, 15ml, and 20ml pack sizes?
Initial volume requirements usually start at 5,000 to 10,000 units per SKU. As saline sprays are high-volume, year-round OTC products, our sterile liquid filling lines in Baddi are engineered to seamlessly scale your production to 2,00,000+ units per batch to meet market demand.
Does Saar Biotech manufacture both the Isotonic and Hypertonic variants?
Yes, we are fully equipped to manufacture both the Isotonic (0.65% w/v) and Hypertonic (2.6% w/v) variants. Furthermore, we offer customizable preservative systems, including standard Benzalkonium Chloride (0.01%) or a highly stable dual-preservative system utilizing Benzalkonium Chloride (0.001%) paired with Phenylmercuric Acetate (0.002%).
How is sterility maintained during the manufacturing of this nasal spray?
Sterility is non-negotiable for nasal and ophthalmic products. This formulation is manufactured in our dedicated ISO Class 7 cleanrooms using high-grade purified water (WFI grade). The filling and sealing processes are fully automated to minimize human intervention, and every batch undergoes rigorous Microbial Limit Tests (MLT) prior to release.
Can you assist with the regulatory and packaging compliance for a new OTC nasal brand?
Absolutely. Operating from our central office in Chandigarh with manufacturing in Baddi, our regulatory team provides complete end-to-end support. This includes brand name availability searches, DCGI compliance reviews, and ensuring that your mono-carton, label, and instructional inserts meet all the latest Schedule M requirements.
What is the standard production turnaround time for a sterile nasal spray order?
New third-party manufacturing agreements for sterile nasal sprays typically conclude within 30–45 working days from the finalization of artwork and packaging procurement. For established distribution partners placing repeat bulk orders, we can expedite delivery to approximately 20–25 working days, ensuring your supply chain remains uninterrupted.
Call Us
WhatsApp
Email